SCHEMBL6287580

SCHEMBL6287580

CC(C)(C)OC(=O)NCCCC[C@@](N)(C(=O)Cc1c[nH]c2ccc(OCc3ccccc3)cc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccc(OCc5ccccc5)cc34)cc2)c2ccc(NC(=O)[C@@](N)(CCCCNC(=O)OC(C)(C)C)C(=O)Cc3c[nH]c4ccc(OCc5ccccc5)cc34)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.47
LTA4H P09960 6/20 0.45
PLA2G2A P14555 6/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
SIRT2 Q8IXJ6 2/20 0.42
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
POLB P06746 1/20 0.40
MTNR1A P48039 2/20 0.40
MTNR1B P49286 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
SLC6A4 P31645 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6284135 0.90 MAPT (0.43) MEN1KMT2AMTNR1AMTNR1BKDM4E
SCHEMBL7036790 0.88 TRPV1 (0.41) KDM4EMAPT
Hydrochloric Acid SCHEMBL6287098 0.88 LTA4H (0.49) TRPM8LTA4HPLA2G2AMEN1KMT2A
SCHEMBL6287996 0.87 CTSL (0.41) MEN1KMT2AMAPTHDAC3HDAC4
SCHEMBL6290422 0.86 CAMK2D (0.42) MEN1KMT2AMTNR1AMTNR1BHDAC3
SCHEMBL6290282 0.86 ANO1 (0.39) SIRT2MTNR1AMTNR1BMAPTSLC6A4
SCHEMBL6286975 0.86 LTA4H (0.45) LTA4HMEN1KMT2AHDAC1
SCHEMBL6290830 0.85 MAPT (0.42) TRPM8SIRT2POLBMAPTSIRT1
SCHEMBL6287290 0.80 GOT1 (0.42) MEN1KMT2AMAPT
SCHEMBL6291033 0.80 MAPT (0.45) MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK TRPM8 4148/4885LTA4H 1938/4885PLA2G2A 3766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.